v3.25.2
Unaudited Condensed Interim Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:          
Net Profit (loss) $ (13,318) $ (6,305) $ (14,044) $ (16,034) $ (30,224)
Adjustments to profit and loss items:          
Depreciation and amortization 394 357 752 725 1,483
Share-based compensation 862 758 1,706 1,270 3,138
Revaluation of warrants accounted at fair value 6,647 1,927 2,377 8,007 10,704
Revaluation of liabilities in respect of IIA grants 203 237 446 470 752
Revaluation of liabilities in respect of TEVA 0 99 0 206 770
Financing income and exchange differences of lease liability 938 (11) 943 17 487
Increase in severance pay liability, net 48 13 75 48 (30)
Other expense 0 0 4 0 18
Financial income, net (424) (405) (942) (918) (2,039)
Un-realized foreign currency loss (6) 11 (21) 78 47
Adjustments to profit and loss items, total 8,662 2,986 5,340 9,903 15,330
Changes in asset and liability items:          
Decrease (increase) in trade receivables (1,671) 876 (217) 753 (1,141)
Decrease (increase) in inventories (263) 103 (1,151) (345) 187
Decrease (increase) in other receivables 37 (459) (341) (574) 120
Increase (decrease) in trade payables and accrued expenses 794 (530) 691 (1,900) 406
Increase in grants received in advance 0 0 0 0 1,181
Decrease in other payables 3 (294) (144) (34) 517
Changes in asset and liability items, total (1,100) (304) (1,162) (2,100) 1,270
Net cash used in operating activities (5,756) (3,623) (9,866) (8,231) (13,624)
Cash Flows from Investing Activities:          
Purchase of property and equipment (1,049) (3,016) (2,008) (4,275) (6,273)
Interest received 319 522 585 1,127 2,252
Proceeds from (investment in) short term bank deposits, net 5,635 5,339 2,985 4,209 (4,376)
Net cash provided by (used in) investing activities 4,905 2,845 1,562 1,061 (8,397)
Cash Flows from Financing Activities:          
Repayment of leases liabilities (289) (214) (537) (458) (928)
Proceeds from exercise of warrants 838 111 838 610 1,210
Proceeds from issuance of shares and warrants, net 0 0 0 0 22,165
Repayment of IIA grants, net 0 0 (114) (120) (219)
Repayment of liabilities in respect of TEVA 0 0 0 (834) (2,834)
Net cash provided by (used in) financing activities 549 (103) 187 (802) 19,394
Exchange rate differences on cash and cash equivalent balances 2 (15) 21 (104) (84)
Decrease in cash and cash equivalents (300) (896) (8,096) (8,076) (2,711)
Balance of cash and cash equivalents at the beginning of the period 1,359 4,686 9,155 11,866 11,866
Balance of cash and cash equivalents at the end of the period 1,059 3,790 1,059 3,790 9,155
Supplement disclosure of Non-cash transactions:          
ROU asset, net recognized with corresponding lease liability 1,080 0 1,254 365 479
Purchase Of Property And Equipment $ (91) $ (43) $ (249) $ (142) $ (344)